Evaluation of Vitrase as a Spreading Agent

Completed · Phase 3

Conditions studied: Pain

In brief

The purpose of this study is to determine whether Vitrase (hyaluronidase for injection) is effective as a spreading agent for other injected drugs prior to ocular surgery

Key facts

Study ID
NCT00198484
Run by
Bausch & Lomb Incorporated
People needed
108
Starts
2004-10-01
Expected to finish
2005-02-01
Last updated by the study team
2013-03-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.